Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine - Concepedia

Concepedia

Publication | Open Access

Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine

DOI Full Paper Access

49

Citations

33

References

2017

Year

Maria Cosenza, Monica Civallero, Luigi Marcheselli, Stefano Sacchi, Samantha Pozzi

Anti-lymphoma Cell ActivityMedicineSelective Hdac6 InhibitorPharmacologyPathologyAnti-cancer AgentCancer TreatmentOncologyNovel TherapyCancer ResearchDrug Discovery

References

	Year	Citations

Page 1